department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Loqtorzi · pharmadog

pharmadog
drugs
Loqtorzi

drug · antibody

patient view →

toripalimab

Phase 2updated 2mo ago

by $CHRS Coherus Oncology, Inc.🔗 ChEMBL

Phase 2

community read0 votes

Antibody drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 52 investigational indications.

indications

indications

Melanoma

targets

Programmed cell death protein 1

all catalysts(1)

phase 2 completion · 1

News(0)

no news has mentioned this drug yet

brand

Loqtorzi

trade names

Loqtorzi

generic

toripalimab-tpzi

MOA

Programmed cell death protein 1 antagonist

indication

Esophageal Squamous Cell Carcinoma (ESCC)

phase

phase_2

phase 2 completion

Shanghai Longfine Biotechnology Co Ltd — toripalimab (Phase II Trial Completion)

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 49m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 3

tagBreast Cancer3 co-mentions · 1 sources
tagOncology2 co-mentions · 1 sources
companyShanghai Longfine Biotechnology Co Ltd1 co-mentions · 1 sources

Trials studying toripalimab

EP1An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumorsrecruitingn=60
EP1An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumorsnot yet recruitingn=50
phase2Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancerrecruitingn=60
phase3LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinomarecruitingn=400
phase2A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung CancerInhibitors or Platinum-Based Agents for Small Cell Lung Cancer.not yet recruitingn=200
phase1A Clinical Study for the Safety and Efficacy of BL0020 Injection in Combination With Toripalimab Injection in Patients With Recurrent Extensive-Stage Small Cell Lung Cancernot yet recruitingn=33
phase2Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)recruitingn=75
phase2STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomasrecruitingn=107

more trials →